CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-13 | Watanabe Todd Franklin Director | Sale | −441 | $17.00 | $7K | 377,466 |
| 2023-02-13 | Watanabe Todd Franklin Director | Sale | −42 | $17.01 | $714 | 377,424 |
| 2023-02-01 | Watanabe Todd Franklin Director | Sale | −618 | $17.00 | $11K | 378,289 |
| 2023-02-01 | Watanabe Todd Franklin Director | Sale | −382 | $17.00 | $6K | 377,907 |
| 2023-01-17 | Welgus Howard G. Director | Exercise or conversion | +8,500 | $1.68 | $14K | 174,325 |
| 2023-01-17 | Welgus Howard G. Director | Sale | −8,500 | $13.72 | $117K | 165,825 |
| 2023-01-17 | Welgus Howard G. Director | Exercise or conversion · Stock Option (right to buy) | −8,500 | 31,958 | ||
| 2023-01-03 | Burnett Patrick | Sale | −1,475 | $15.01 | $22K | 41,564 |
| 2022-12-07 | Watanabe Todd Franklin Director | Sale | −1,000 | $17.06 | $17K | 378,907 |
| 2022-11-21 | Matsuda Masaru | Sale | −1,720 | $18.19 | $31K | 19,535 |
| 2022-11-18 | Matsuda Masaru | Grant or award | +4,875 | 21,255 | ||
| 2022-11-15 | Welgus Howard G. Director | Exercise or conversion | +1,020 | $1.68 | $2K | 169,228 |
| 2022-11-15 | Welgus Howard G. Director | Sale | −3,403 | $20.01 | $68K | 165,825 |
| 2022-11-15 | Welgus Howard G. Director | Exercise or conversion · Stock Option (right to buy) | −1,020 | 40,458 | ||
| 2022-11-07 | Watanabe Todd Franklin Director | Sale | −1,000 | $18.00 | $18K | 379,907 |
| 2022-10-07 | Watanabe Todd Franklin President and CEO | Sale | −1,000 | $19.51 | $20K | 380,907 |
| 2022-10-04 | Welgus Howard G. Director | Sale | −6,000 | $20.29 | $122K | 168,208 |
| 2022-09-16 | Burrows Scott L Chief Financial Officer | Exercise or conversion | +5,000 | $1.68 | $8K | 40,256 |
| 2022-09-16 | Burrows Scott L Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 37,277 | ||
| 2022-09-07 | Watanabe Todd Franklin President and CEO | Sale | −1,000 | $21.51 | $22K | 381,907 |
Page 27 of 35 · 689 trades